Global Short Read Sequencing Market 2024 - By Industry Research, Future Growth, Latest Trends And Forecast To 2033

The short read sequencing market size has grown rapidly in recent years. It will grow from $5.74 billion in 2023 to $6.82 billion in 2024 at a compound annual growth rate (CAGR) of 18.9%. The growth in the historic period can be attributed to genomic research initiatives, increased prevalence of genetic disorders, pharmaceutical and biotech research, diagnostic applications, declining sequencing costs..

The short read sequencing market size is expected to see rapid growth in the next few years. It will grow to $12.97 billion in 2028 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to precision medicine advancements, rapid growth in personalized genomics, expanding applications in agriculture, surge in microbiome research, rising demand in emerging markets.. Major trends in the forecast period include automation and high-throughput, cloud-based solutions, integration of ai and machine learning, portable sequencing technologies, long-read sequencing synergy..

Market Overview -
Short-read sequencing, or next-generation sequencing (NGS), is a high-throughput DNA sequencing method that generates short fragments or reads of DNA sequences. It revolutionized genomics by enabling the rapid and cost-effective analysis of entire genomes and transcriptomes.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11912&type=smp

Short-Read Sequencing Market Driven By Surging Prevalence Of Genetic Diseases
The rising prevalence of genetic diseases is expected to propel the growth of the short-read sequencing market going forward. Genetic diseases are conditions caused by abnormalities or mutations in an individual's DNA or genes, leading to physical, developmental, or biochemical abnormalities that can impact their health and well-being. Short-read sequencing is used in genetic diseases to analyze the genome and identify disease-associated variants comprehensively. For instance, in June 2022, according to a report published by RARE-X, an Australia-based patient support platform, there were a total of 10,867 rare diseases, encompassing both genetic and non-genetic conditions. Therefore, the rising prevalence of genetic diseases is driving the growth of the short-read sequencing market.

Competitive Landscape -
Major companies operating in the short read sequencing market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Cytiva Lifesciences, Eurofins Scientific SE, Agilent Technologies Inc., Beckman Coulter Inc., Illumina Inc., QIAGEN N.V., PerkinElmer Inc., BGI Genomics Co Ltd, MGI Tech Co. Ltd., GenScript Biotech Corporation., 10x Genomics Inc., Novogene Co. Ltd, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., Genewiz Inc., Zymo Research Corporation, GenapSys Inc., Fasteris SA, GnuBIO Inc., Paragon Genomics Inc., Nabsys Inc., GATC Biotech AG, Halcyon Molecular Inc.

Short-Read Sequencing Market Advances With Cutting-Edge Technology Innovations
Technology advancements are the key trend gaining popularity in the short-read sequencing market. Major companies involved in the short-read sequencing market are focused on technology advancements to improve their observation power and sustain their position in the market. For instance, in October 2022, Pacific Biosciences Inc, a US-based producer of excellent, highly accurate sequencing technologies, launched external beta testing of the Onso sequencing system. The system was designed to provide precise data while also being cost-effective. The short-read platform was developed to give oncology researchers sensitive and specific targeted sequence analysis findings.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

Key Segments -
The short read sequencing market covered in this report is segmented -
1) By Product: Instruments, Consumables, Services.
2) By Technology: Next-Generation Sequencing, Sanger Sequencing.
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis.
4) By Application: Clinical Investigation, Oncology, Reproductive Health, Consumer Genomics, Agri genomics and Forensics, HLA Typing/ Immune System Monitoring.
5) By End Users: Academic Research, Hospitals and Clinics, Clinical Research, Pharmaceutical and Biotechnology Companies.

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.